Review of EEG microstate analysis shows high diagnostic accuracy for distinguishing neuropsychiatric symptoms from cognitive impairment
This publication is a review of a cross-sectional study involving 78 individuals with cognitive impairment and neuropsychiatric symptoms. The authors utilized EEG microstate analysis to distinguish patients with neuropsychiatric symptoms from those with cognitive impairment. The primary outcome measured diagnostic model performance using area under the curve, sensitivity, and specificity. No medications were evaluated in this analysis.
The diagnostic model for distinguishing neuropsychiatric patients from cognitive impairment patients achieved an area under the curve of 0.905. The 95% confidence interval for the AUC ranged from 0.784 to 1.000. Sensitivity was reported as 100.0% and specificity was 76.9%. These metrics indicate strong potential for diagnostic differentiation in this specific clinical context.
Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. Funding or conflicts of interest were not reported. The study limitations include the small sample size and the cross-sectional design. Practice relevance remains uncertain due to the lack of longitudinal data and generalizability concerns inherent in this study design.